MiniMed Group, Inc. (MMED)
17.81
+0.32
(+1.83%)
USD |
NASDAQ |
Oct 19, 15:49
MiniMed Group Enterprise Value : 4.770B for Oct. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 16, 2026 | 4.770B |
| October 15, 2026 | 4.914B |
| October 14, 2026 | 4.579B |
| October 13, 2026 | 5.026B |
| October 12, 2026 | 5.139B |
| October 09, 2026 | 5.395B |
| October 08, 2026 | 5.420B |
| October 07, 2026 | 5.226B |
| October 06, 2026 | 5.375B |
| October 05, 2026 | 5.521B |
| October 02, 2026 | 5.392B |
| October 01, 2026 | 5.364B |
| September 30, 2026 | 5.327B |
| September 29, 2026 | 5.487B |
| September 28, 2026 | 5.614B |
| September 25, 2026 | 5.470B |
| September 24, 2026 | 5.600B |
| September 23, 2026 | 5.628B |
| September 22, 2026 | 5.814B |
| September 21, 2026 | 5.791B |
| September 18, 2026 | 5.979B |
| September 17, 2026 | 6.047B |
| September 16, 2026 | 6.151B |
| September 15, 2026 | 6.041B |
| September 14, 2026 | 6.030B |
| Date | Value |
|---|---|
| September 11, 2026 | 6.179B |
| September 10, 2026 | 6.162B |
| September 09, 2026 | 6.252B |
| September 08, 2026 | 6.410B |
| September 04, 2026 | 6.400B |
| September 03, 2026 | 6.556B |
| September 02, 2026 | 6.533B |
| September 01, 2026 | 6.157B |
| August 31, 2026 | 5.549B |
| August 28, 2026 | 5.504B |
| August 27, 2026 | 5.338B |
| August 26, 2026 | 5.333B |
| August 25, 2026 | 5.172B |
| August 24, 2026 | 5.459B |
| August 21, 2026 | 5.603B |
| August 20, 2026 | 5.527B |
| August 19, 2026 | 5.538B |
| August 18, 2026 | 5.296B |
| August 17, 2026 | 5.344B |
| August 14, 2026 | 5.518B |
| August 13, 2026 | 5.482B |
| August 12, 2026 | 5.673B |
| August 11, 2026 | 5.414B |
| August 10, 2026 | 5.336B |
| August 07, 2026 | 5.364B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 209.16B |
| Baxter International, Inc. | 19.75B |
| Becton, Dickinson & Co. | 68.17B |
| Boston Scientific Corp. | 76.44B |
| DexCom, Inc. | 31.92B |
Enterprise Value Related Metrics
| Revenue (Quarterly) | 843.00M |
| Total Expenses (Quarterly) | 843.00M |
| Gross Profit Margin (Quarterly) | 55.04% |
| Earnings Yield | -6.42% |
| Operating Earnings Yield | 7.98% |
| Normalized Earnings Yield | -0.7221 |